Cargando…

Insulin Resistance Remission Following Laparoscopic Roux-en-Y Gastric Bypass and Laparoscopic Sleeve Gastrectomy in Chinese Type 2 Diabetes Mellitus Patients With a Body Mass Index of 27.5–32.5 kg/m(2)

Background: Insulin resistance (IR) is closely associated with the pathogenesis of type 2 diabetes mellitus (T2DM). However, remission of insulin sensitivity after bariatric surgery in patients with T2DM and a body mass index (BMI) of 27.5–32.5 kg/m(2) has not been fully elucidated. Methods: Thirty-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Ping, Cao, Yaoquan, Li, Pengzhou, Wang, Guohui, Song, Zhi, Li, Weizheng, Su, Zhihong, Zhou, Hui, Yi, Xianhao, Fu, Zhibing, Sun, Xulong, Tang, Haibo, Cui, Beibei, Yu, Qianqian, Zhu, Liyong, Zhu, Shaihong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606571/ https://www.ncbi.nlm.nih.gov/pubmed/34819878 http://dx.doi.org/10.3389/fphys.2021.772577

Ejemplares similares

TyG Index Performs Better Than HOMA-IR in Chinese Type 2 Diabetes Mellitus with a BMI < 35 kg/m(2): A Hyperglycemic Clamp Validated Study
por: Luo, Ping, et al.
Publicado: (2022)

Effect of laparoscopic sleeve gastrectomy on mobilization of site-specific body adipose depots: a prospective cohort study
por: Cui, Beibei, et al.
Publicado: (2023)

Robot-assisted sleeve gastrectomy in patients with obesity with a novel Chinese domestic MicroHand SII surgical system
por: Li, Weizheng, et al.
Publicado: (2021)

Large Versus Small Gastric Pouch for Roux-en-Y Gastric Bypass in Individuals With Type 2 Diabetes and a Body Mass Index < 35 kg/m2: Six-Year Outcomes
por: Gao, Xiang, et al.
Publicado: (2022)

A bibliometric and visual analysis of obesity and polycystic ovary syndrome from 2012 to 2022
por: Luo, Ping, et al.
Publicado: (2022)

Disease-specific mortality and major adverse cardiovascular events after bariatric surgery: a meta-analysis of age, sex, and BMI-matched cohort studies
por: Cui, Beibei, et al.
Publicado: (2023)

Targeting survivin with Tanshinone IIA inhibits tumor growth and overcomes chemoresistance in colorectal cancer
por: Cao, Yaoquan, et al.
Publicado: (2023)

Laparoscopic sleeve gastrectomy combined with single-anastomosis duodenal-jejunal bypass in the treatment of type 2 diabetes mellitus of patients with body mass index higher than 27.5 kg/m(2) but lower than 32.5 kg/m(2)
por: Li, Ying-Xu, et al.
Publicado: (2018)

The predictive value of trunk/leg fat ratio for type 2 diabetes mellitus remission after bariatric surgery: A new observation and insight
por: Cui, Beibei, et al.
Publicado: (2022)

GLP-1-Induced AMPK Activation Inhibits PARP-1 and Promotes LXR-Mediated ABCA1 Expression to Protect Pancreatic β-Cells Against Cholesterol-Induced Toxicity Through Cholesterol Efflux
por: Li, Rao, et al.
Publicado: (2021)

The role of visceral adipose tissue on improvement in insulin sensitivity following Roux-en-Y gastric bypass: a study in Chinese diabetic patients with mild and central obesity
por: Zhao, Lei, et al.
Publicado: (2018)

The role of visceral adipose tissue on improvement in insulin sensitivity following Roux-en-Y gastric bypass: a study in Chinese diabetic patients with mild and central obesity
por: Zhao, Lei, et al.
Publicado: (2018)

Effect of Laparoscopic Sleeve Gastrectomy on the Pharmacokinetics of Oral Omeprazole Using a Population Approach
por: Chen, Kaifeng, et al.
Publicado: (2022)

Long-term weight loss outcome of laparoscopic Roux-en-Y gastric bypass predicted by weight loss at 6 months in Chinese patients with BMI ≥ 32.5 kg/m(2)
por: Wuyun, Qiqige, et al.
Publicado: (2023)

Changes in Adipokines following Laparoscopic Roux-en-Y Gastric Bypass Surgery in Chinese Individuals with Type 2 Diabetes Mellitus and BMI of 22–30 kg·m(−2)
por: Shrestha, Chandrama, et al.
Publicado: (2013)

miR-344-5p Modulates Cholesterol-Induced β-Cell Apoptosis and Dysfunction Through Regulating Caveolin-1 Expression
por: Sun, Xulong, et al.
Publicado: (2021)

Liquid biopsy at the frontier of detection, prognosis and progression monitoring in colorectal cancer
por: Zhou, Hui, et al.
Publicado: (2022)

Is prior bariatric surgery associated with poor COVID-19 outcomes? A systematic review and meta-analysis of case-control studies
por: Gao, Xiang, et al.
Publicado: (2023)

Long-Term Weight Loss Outcome of Laparoscopic Sleeve Gastrectomy Predicted by the Percentage of Excess Weight Loss at 6 Months in Chinese Patients with Body Mass Index ≥ 32.5 Kg/m(2)
por: Wang, Liang, et al.
Publicado: (2022)

From genetics and epigenetics to the future of precision treatment for obesity
por: Sun, Xulong, et al.
Publicado: (2017)

Are Chinese Patients with Type 2 Diabetes and a Body Mass Index of 27.5–32.5 kg/m(2) Suitable for Metabolic Surgery? A One-Year Post-Surgery Study
por: Zhang, Ning-Jing, et al.
Publicado: (2021)

Diagnostic accuracy of the visceral adiposity index in patients with metabolic-associated fatty liver disease: a meta-analysis
por: Yi, Xianhao, et al.
Publicado: (2022)

Laparoscopic Roux-en-Y gastric bypass is as safe as laparoscopic sleeve gastrectomy. Results of a comparative cohort study
por: Lynn, W., et al.
Publicado: (2018)

WHEN SHOULD BE CONVERTED LAPAROSCOPIC SLEEVE GASTRECTOMY TO LAPAROSCOPIC ROUX-EN-Y GASTRIC BYPASS DUE TO GASTROESOPHAGEAL REFLUX?
por: BRAGHETTO, Italo, et al.
Publicado: (2021)

Short- and Midterm Results between Laparoscopic Roux-en-Y Gastric Bypass and Laparoscopic Sleeve Gastrectomy for the Treatment of Morbid Obesity
por: Albeladi, Bandar, et al.
Publicado: (2013)

Cost-effectiveness of laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass in two hospitals of Tehran city in 2014
por: Arabi Basharic, Fateme, et al.
Publicado: (2017)

A meta-analysis of the medium- and long-term effects of laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass
por: Gu, Lihu, et al.
Publicado: (2020)

Diabetes improvement and bariatric surgery—review of laparoscopic Roux-en-Y gastric bypass vs. laparoscopic vertical sleeve gastrectomy
por: Gu, Jeffrey, et al.
Publicado: (2020)

Risk Factors for Prolonged Length of Hospital Stay and Readmissions After Laparoscopic Sleeve Gastrectomy and Laparoscopic Roux-en-Y Gastric Bypass
por: Major, Piotr, et al.
Publicado: (2017)

Safety of Single Stage Revision Laparoscopic Sleeve Gastrectomy Compared to Laparoscopic Roux-Y Gastric Bypass after Failed Gastric Banding
por: Janik, Michał, et al.
Publicado: (2020)

Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in Egyptian patients with morbid obesity
por: Baheeg, Mohamad, et al.
Publicado: (2022)

Effects of Laparoscopic Roux-en-Y Gastric Bypass for Type 2 Diabetes Mellitus: Comparison of BMI > 30 and < 30 kg/m(2)
por: Ke, Zhigang, et al.
Publicado: (2017)

Short-Term Outcomes of Laparoscopic Greater Curvature Plication and Laparoscopic Sleeve Gastrectomy in Patients with a Body Mass Index of 30 to 35 kg/m(2)
por: Park, Yeon Ho, et al.
Publicado: (2017)

The Effects of Laparoscopic Sleeve Gastrectomy on Glucose Metabolism in Patients with a Body Mass Index below 35 kg/m²
por: Batman, Burçin, et al.
Publicado: (2020)

Reviewers BJCVS 32.5
Publicado: (2017)

Decision Regret after Laparoscopic Sleeve Gastrectomy—5 Years’ Perspective
por: Bartosiak, Katarzyna, et al.
Publicado: (2021)

Evaluation of laparoscopic sleeve gastrectomy compared with laparoscopic Roux-en-Y gastric bypass for people with morbid obesity: A systematic review and meta-analysis
por: Arabi Basharic, Fateme, et al.
Publicado: (2016)

Postoperative Care and Functional Recovery After Laparoscopic Sleeve Gastrectomy vs. Laparoscopic Roux-en-Y Gastric Bypass Among Patients Under ERAS Protocol
por: Major, Piotr, et al.
Publicado: (2017)

Laparoscopic Sleeve Gastrectomy versus Laparoscopic Roux-en-Y Gastric Bypass: An Analysis of Weight Loss Using a Multilevel Mixed-Effects Linear Model
por: Pouchucq, Camille, et al.
Publicado: (2023)

Long-term effects of laparoscopic sleeve gastrectomy versus roux-en-Y gastric bypass for the treatment of Chinese type 2 diabetes mellitus patients with body mass index 28-35 kg/m(2)
por: Yang, Jingge, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vijin0gj1sbomkn8d7nkfba8ob